NL7307401A - - Google Patents

Info

Publication number
NL7307401A
NL7307401A NL7307401A NL7307401A NL7307401A NL 7307401 A NL7307401 A NL 7307401A NL 7307401 A NL7307401 A NL 7307401A NL 7307401 A NL7307401 A NL 7307401A NL 7307401 A NL7307401 A NL 7307401A
Authority
NL
Netherlands
Application number
NL7307401A
Other versions
NL164025C (nl
NL164025B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7307401A publication Critical patent/NL7307401A/xx
Publication of NL164025B publication Critical patent/NL164025B/xx
Application granted granted Critical
Publication of NL164025C publication Critical patent/NL164025C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
NL7307401.A 1973-04-09 1973-05-28 Werkwijze voor het bereiden van een preparaat met vaat- verwijdende en antispasmodische werkzaamheid op basis van een 1-(4-alkylthiofenyl)-2-aminoalkanol, volgens deze werkwijze verkregen gevormd preparaat en werkwijze voor het bereiden van een geneeskrachtig 1-(4-alkylthiofenyl)-2-aminoalkanol, geschikt voor gebruik bij de genoemde werkwijze. NL164025C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1700173A GB1390748A (en) 1973-04-09 1973-04-09 Alkyl and cycloalkylthiophenylalkylaminoalkanols their salts and the preparation thereof

Publications (3)

Publication Number Publication Date
NL7307401A true NL7307401A (de) 1974-10-11
NL164025B NL164025B (nl) 1980-06-16
NL164025C NL164025C (nl) 1980-11-17

Family

ID=10087466

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7307401.A NL164025C (nl) 1973-04-09 1973-05-28 Werkwijze voor het bereiden van een preparaat met vaat- verwijdende en antispasmodische werkzaamheid op basis van een 1-(4-alkylthiofenyl)-2-aminoalkanol, volgens deze werkwijze verkregen gevormd preparaat en werkwijze voor het bereiden van een geneeskrachtig 1-(4-alkylthiofenyl)-2-aminoalkanol, geschikt voor gebruik bij de genoemde werkwijze.

Country Status (11)

Country Link
US (1) US4228187A (de)
JP (1) JPS5221497B2 (de)
BE (1) BE799379R (de)
CH (1) CH555315A (de)
DE (2) DE2334404C2 (de)
ES (1) ES425084A2 (de)
FR (1) FR2224148B2 (de)
GB (1) GB1390748A (de)
IL (1) IL42448A (de)
NL (1) NL164025C (de)
ZA (1) ZA742227B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034035A (en) * 1975-07-14 1977-07-05 Merck & Co., Inc. Method of preparing multi-toned tablets
FR2353288A1 (fr) * 1976-06-04 1977-12-30 Continental Pharma Composition pharmaceutique hydrosoluble a base d'un compose amine comme produit actif
DE2817494A1 (de) * 1977-05-03 1978-11-09 Continental Pharma Aminoalkohol-derivat
US4404222A (en) * 1980-08-25 1983-09-13 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and improving the efficiency of feed utilization thereby
DE3128117A1 (de) * 1980-07-29 1982-03-11 Yamanouchi Pharmaceutical Co., Ltd., Tokyo Neue phenyl-aethylaminderivate, verfahren zu ihrer herstellung
US4407819A (en) * 1980-08-25 1983-10-04 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals
US4432995A (en) * 1980-12-22 1984-02-21 American Cyanamid Company 5-[2-(Ethylamino)-1-hydroxylethyl] anthranilonitrile and the use thereof in meat producing animals
AT380874B (de) * 1980-12-24 1986-07-25 Continental Pharma Verfahren zur herstellung von 1-(4-isopropylthiophenyl)-2-n.octyl-amino-propanol, dessen saeureadditionssalzen und estern
AT380873B (de) * 1980-12-24 1986-07-25 Continental Pharma Verfahren zur herstellung von 1-(4-isopropylthiophenyl)-2-n.octyl-amino -propanol, dessen saeureadditionssalzen und estern
LU83039A1 (fr) * 1980-12-24 1982-07-07 Continental Pharma Procedes de synthese du 1-(4 isopropylthiophenyl)-2-n octylaminopropanol
DE3262620D1 (en) * 1981-05-27 1985-04-25 Maggioni Farma 4-alkyl-thiophenyl-ethanolamines, having an activity on the cerebral circulation, the blood platelet-aggregation and the lipemia
IT1198386B (it) * 1982-07-06 1988-12-21 Lepetit Spa Un prodotto a rilascio protratto contenente il suloctidile
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
US5541188A (en) * 1987-09-15 1996-07-30 The Rowett Research Institute Therapeutic applications of beta-adrenergic agonists
US5530029A (en) * 1987-09-15 1996-06-25 The Rowett Research Institute Therapeutic applications of clenbuterol
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
GB201015079D0 (en) * 2010-09-10 2010-10-27 Helperby Therapeutics Ltd Novel use
EP2986599A1 (de) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamid-derivate zur behandlung von herz-kreislauf-erkrankungen
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same

Also Published As

Publication number Publication date
IL42448A0 (en) 1973-08-29
ZA742227B (en) 1975-06-25
BE799379R (fr) 1973-11-12
DE2334404A1 (de) 1974-10-24
GB1390748A (en) 1975-04-16
IL42448A (en) 1976-09-30
NL164025C (nl) 1980-11-17
FR2224148B2 (de) 1976-10-22
NL164025B (nl) 1980-06-16
CH555315A (fr) 1974-10-31
DE2366338C2 (de) 1982-06-16
JPS49135935A (de) 1974-12-27
US4228187A (en) 1980-10-14
DE2334404C2 (de) 1982-10-28
ES425084A2 (es) 1976-12-16
JPS5221497B2 (de) 1977-06-10
FR2224148A2 (de) 1974-10-31

Similar Documents

Publication Publication Date Title
AR201758A1 (de)
AU476761B2 (de)
AR201235Q (de)
AR201231Q (de)
AU474593B2 (de)
FR2224148B2 (de)
AU474838B2 (de)
AU476714B2 (de)
AR201229Q (de)
AU476696B2 (de)
AR199451A1 (de)
AU477823B2 (de)
AR193950A1 (de)
AR196382A1 (de)
AR200256A1 (de)
AU476873B1 (de)
AR195948A1 (de)
AR201432A1 (de)
AR195311A1 (de)
AU477824B2 (de)
AR210729A1 (de)
AR197627A1 (de)
AR200885A1 (de)
AU447540B2 (de)
AR196212Q (de)

Legal Events

Date Code Title Description
SNR Assignments of patents or rights arising from examined patent applications

Owner name: CONTINENTAL PHARMA, INC.

V1 Lapsed because of non-payment of the annual fee